Plasma from poorly mobilizing human subjects inhibits cytokine-induced murine blood stem-cell mobilization

John G Sharp, Timothy R McGuire, Sl Mann, B. Murphy, A. Kessinger

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Background: Cytokine-induced mobilization of hematopoietic stem/progenitor cells to the circulation facilitates efficient harvest of blood stem cells by leukapheresis. Up to 30% of autologous, and 10-20% of allogeneic blood stem-cell donors respond poorly to mobilizing cytokines and preliminary studies implicated a circulating inhibitor of mobilization. Methods: In this study, plasma from 11 allogeneic and 23 autologous stem cell donors was assayed for inhibition of mobilization in mice. Results: There were significant correlations between CD34+ cells collected/kg human donor weight and spleen weight, CD34+ CD45+ cells, GM-CFC and HPP-CFC per spleen in murine recipients of these plasma samples. Overall, there was a positive association between transforming growth factor β (TGF-β) levels and CD34+ cells per liter of blood processed (LBP). However, when arbitrarily segregated into good versus poor mobilizer, based on less or greater than 15 million CD34+ cells collected per LBP, the majority (64%) of normal donors were good mobilizers. The majority of the poor mobilizers (83%) were patients. For a subset of 12 individuals whose plasma strongly inhibited mobilization in the mouse, a significant positive correlation of the extent of inhibition with TGF-β levels was found. For 11 individuals whose plasma, based on colony assays, enhanced mobilization when injected into mice, no correlation with TGF-β levels was evident. Discussion: Elevated plasma TGF-β levels in some stem-cell donors may be associated with poor stem-cell mobilization. It remains to be determined whether elevation of TGF-β levels is a cause of, or a compensatory response to, poor mobilization.

Original languageEnglish (US)
Pages (from-to)365-373
Number of pages9
JournalCytotherapy
Volume4
Issue number4
DOIs
StatePublished - Jan 1 2002

Fingerprint

Hematopoietic Stem Cell Mobilization
Transforming Growth Factors
Blood Cells
Tissue Donors
Cytokines
Stem Cells
Hematopoietic Stem Cells
Spleen
Leukapheresis
Weights and Measures

Keywords

  • Inhibition of (stem cell) mobilization
  • TGF-β

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology
  • Oncology
  • Genetics(clinical)
  • Cell Biology
  • Transplantation
  • Cancer Research

Cite this

Plasma from poorly mobilizing human subjects inhibits cytokine-induced murine blood stem-cell mobilization. / Sharp, John G; McGuire, Timothy R; Mann, Sl; Murphy, B.; Kessinger, A.

In: Cytotherapy, Vol. 4, No. 4, 01.01.2002, p. 365-373.

Research output: Contribution to journalArticle

@article{f53e17b61fa24cfdac039a9d8c3bc283,
title = "Plasma from poorly mobilizing human subjects inhibits cytokine-induced murine blood stem-cell mobilization",
abstract = "Background: Cytokine-induced mobilization of hematopoietic stem/progenitor cells to the circulation facilitates efficient harvest of blood stem cells by leukapheresis. Up to 30{\%} of autologous, and 10-20{\%} of allogeneic blood stem-cell donors respond poorly to mobilizing cytokines and preliminary studies implicated a circulating inhibitor of mobilization. Methods: In this study, plasma from 11 allogeneic and 23 autologous stem cell donors was assayed for inhibition of mobilization in mice. Results: There were significant correlations between CD34+ cells collected/kg human donor weight and spleen weight, CD34+ CD45+ cells, GM-CFC and HPP-CFC per spleen in murine recipients of these plasma samples. Overall, there was a positive association between transforming growth factor β (TGF-β) levels and CD34+ cells per liter of blood processed (LBP). However, when arbitrarily segregated into good versus poor mobilizer, based on less or greater than 15 million CD34+ cells collected per LBP, the majority (64{\%}) of normal donors were good mobilizers. The majority of the poor mobilizers (83{\%}) were patients. For a subset of 12 individuals whose plasma strongly inhibited mobilization in the mouse, a significant positive correlation of the extent of inhibition with TGF-β levels was found. For 11 individuals whose plasma, based on colony assays, enhanced mobilization when injected into mice, no correlation with TGF-β levels was evident. Discussion: Elevated plasma TGF-β levels in some stem-cell donors may be associated with poor stem-cell mobilization. It remains to be determined whether elevation of TGF-β levels is a cause of, or a compensatory response to, poor mobilization.",
keywords = "Inhibition of (stem cell) mobilization, TGF-β",
author = "Sharp, {John G} and McGuire, {Timothy R} and Sl Mann and B. Murphy and A. Kessinger",
year = "2002",
month = "1",
day = "1",
doi = "10.1080/146532402760271154",
language = "English (US)",
volume = "4",
pages = "365--373",
journal = "Cytotherapy",
issn = "1465-3249",
publisher = "Informa Healthcare",
number = "4",

}

TY - JOUR

T1 - Plasma from poorly mobilizing human subjects inhibits cytokine-induced murine blood stem-cell mobilization

AU - Sharp, John G

AU - McGuire, Timothy R

AU - Mann, Sl

AU - Murphy, B.

AU - Kessinger, A.

PY - 2002/1/1

Y1 - 2002/1/1

N2 - Background: Cytokine-induced mobilization of hematopoietic stem/progenitor cells to the circulation facilitates efficient harvest of blood stem cells by leukapheresis. Up to 30% of autologous, and 10-20% of allogeneic blood stem-cell donors respond poorly to mobilizing cytokines and preliminary studies implicated a circulating inhibitor of mobilization. Methods: In this study, plasma from 11 allogeneic and 23 autologous stem cell donors was assayed for inhibition of mobilization in mice. Results: There were significant correlations between CD34+ cells collected/kg human donor weight and spleen weight, CD34+ CD45+ cells, GM-CFC and HPP-CFC per spleen in murine recipients of these plasma samples. Overall, there was a positive association between transforming growth factor β (TGF-β) levels and CD34+ cells per liter of blood processed (LBP). However, when arbitrarily segregated into good versus poor mobilizer, based on less or greater than 15 million CD34+ cells collected per LBP, the majority (64%) of normal donors were good mobilizers. The majority of the poor mobilizers (83%) were patients. For a subset of 12 individuals whose plasma strongly inhibited mobilization in the mouse, a significant positive correlation of the extent of inhibition with TGF-β levels was found. For 11 individuals whose plasma, based on colony assays, enhanced mobilization when injected into mice, no correlation with TGF-β levels was evident. Discussion: Elevated plasma TGF-β levels in some stem-cell donors may be associated with poor stem-cell mobilization. It remains to be determined whether elevation of TGF-β levels is a cause of, or a compensatory response to, poor mobilization.

AB - Background: Cytokine-induced mobilization of hematopoietic stem/progenitor cells to the circulation facilitates efficient harvest of blood stem cells by leukapheresis. Up to 30% of autologous, and 10-20% of allogeneic blood stem-cell donors respond poorly to mobilizing cytokines and preliminary studies implicated a circulating inhibitor of mobilization. Methods: In this study, plasma from 11 allogeneic and 23 autologous stem cell donors was assayed for inhibition of mobilization in mice. Results: There were significant correlations between CD34+ cells collected/kg human donor weight and spleen weight, CD34+ CD45+ cells, GM-CFC and HPP-CFC per spleen in murine recipients of these plasma samples. Overall, there was a positive association between transforming growth factor β (TGF-β) levels and CD34+ cells per liter of blood processed (LBP). However, when arbitrarily segregated into good versus poor mobilizer, based on less or greater than 15 million CD34+ cells collected per LBP, the majority (64%) of normal donors were good mobilizers. The majority of the poor mobilizers (83%) were patients. For a subset of 12 individuals whose plasma strongly inhibited mobilization in the mouse, a significant positive correlation of the extent of inhibition with TGF-β levels was found. For 11 individuals whose plasma, based on colony assays, enhanced mobilization when injected into mice, no correlation with TGF-β levels was evident. Discussion: Elevated plasma TGF-β levels in some stem-cell donors may be associated with poor stem-cell mobilization. It remains to be determined whether elevation of TGF-β levels is a cause of, or a compensatory response to, poor mobilization.

KW - Inhibition of (stem cell) mobilization

KW - TGF-β

UR - http://www.scopus.com/inward/record.url?scp=0036383423&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036383423&partnerID=8YFLogxK

U2 - 10.1080/146532402760271154

DO - 10.1080/146532402760271154

M3 - Article

VL - 4

SP - 365

EP - 373

JO - Cytotherapy

JF - Cytotherapy

SN - 1465-3249

IS - 4

ER -